BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening?
bioAffinity Technologies is surging Wednesday as traders digest recent commercial expansion news alongside tight low-float trading dynamics.
Read original at benzingaStocks · News reference
BioAffinity Advances Noninvasive CyPath Lung Test For Post-Treatment Monitoring
bioAffinity stock trades higher as it advances its CyPath Lung test for post-treatment lung cancer surveillance.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Surges Over 200 Points; Ollie's Bargain Outlet Shares Gain After Q2 Earnings
U.S. stocks edged higher, led by the Dow and materials. Ollie’s beat EPS estimates; biotech and AI shares surged, while Tscan plunged 26%.
Read original at benzingaCrude Oil Surges 3%; ISM Manufacturing PMI Falls In August
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 points on Tuesday.The Dow traded down 0.40% to 52,971.81 while the NASDAQ dipped 0.52% to 26,232.46. The S&P 500 also
Read original at benzinga